These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30988014)

  • 1. Antagonism of Forkhead Box Subclass O Transcription Factors Elicits Loss of Soluble Guanylyl Cyclase Expression.
    Galley JC; Durgin BG; Miller MP; Hahn SA; Yuan S; Wood KC; Straub AC
    Mol Pharmacol; 2019 Jun; 95(6):629-637. PubMed ID: 30988014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoxO4 controls sGCβ transcription in vascular smooth muscle.
    Galley JC; Miller MP; Sanker S; Liu M; Sharina I; Martin E; Gomez D; Straub AC
    Am J Physiol Heart Circ Physiol; 2022 Mar; 322(3):H417-H426. PubMed ID: 35089807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional Characterization of the
    Kessler T; Wobst J; Wolf B; Eckhold J; Vilne B; Hollstein R; von Ameln S; Dang TA; Sager HB; Moritz Rumpf P; Aherrahrou R; Kastrati A; Björkegren JLM; Erdmann J; Lusis AJ; Civelek M; Kaiser FJ; Schunkert H
    Circulation; 2017 Aug; 136(5):476-489. PubMed ID: 28487391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
    Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
    Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional role of the soluble guanylyl cyclase alpha(1) subunit in vascular smooth muscle relaxation.
    Nimmegeers S; Sips P; Buys E; Brouckaert P; Van de Voorde J
    Cardiovasc Res; 2007 Oct; 76(1):149-59. PubMed ID: 17610859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytochrome b5 Reductase 3 Modulates Soluble Guanylate Cyclase Redox State and cGMP Signaling.
    Rahaman MM; Nguyen AT; Miller MP; Hahn SA; Sparacino-Watkins C; Jobbagy S; Carew NT; Cantu-Medellin N; Wood KC; Baty CJ; Schopfer FJ; Kelley EE; Gladwin MT; Martin E; Straub AC
    Circ Res; 2017 Jul; 121(2):137-148. PubMed ID: 28584062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of nitrovasodilator-induced cyclic GMP accumulation in cells exposed to endotoxin or interleukin-1 beta.
    Papapetropoulos A; Abou-Mohamed G; Marczin N; Murad F; Caldwell RW; Catravas JD
    Br J Pharmacol; 1996 Jul; 118(6):1359-66. PubMed ID: 8832057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of YC-1, an NO-independent, superoxide-sensitive stimulator of soluble guanylyl cyclase, on smooth muscle responsiveness to nitrovasodilators.
    Mülsch A; Bauersachs J; Schäfer A; Stasch JP; Kast R; Busse R
    Br J Pharmacol; 1997 Feb; 120(4):681-9. PubMed ID: 9051308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-κB-responsive miR-155 induces functional impairment of vascular smooth muscle cells by downregulating soluble guanylyl cyclase.
    Park M; Choi S; Kim S; Kim J; Lee DK; Park W; Kim T; Jung J; Hwang JY; Won MH; Ryoo S; Kang SG; Ha KS; Kwon YG; Kim YM
    Exp Mol Med; 2019 Feb; 51(2):1-12. PubMed ID: 30765689
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soluble guanylyl cyclase (sGC) degradation and impairment of nitric oxide-mediated responses in urethra from obese mice: reversal by the sGC activator BAY 60-2770.
    Alexandre EC; Leiria LO; Silva FH; Mendes-Silvério CB; Calmasini FB; Davel AP; Mónica FZ; De Nucci G; Antunes E
    J Pharmacol Exp Ther; 2014 Apr; 349(1):2-9. PubMed ID: 24421320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of nitric oxide from endothelial cells stimulated by YC-1, an activator of soluble guanylyl cyclase.
    Wohlfart P; Malinski T; Ruetten H; Schindler U; Linz W; Schoenafinger K; Strobel H; Wiemer G
    Br J Pharmacol; 1999 Nov; 128(6):1316-22. PubMed ID: 10578147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of soluble guanylyl cyclase redox state by hydrogen sulfide.
    Zhou Z; Martin E; Sharina I; Esposito I; Szabo C; Bucci M; Cirino G; Papapetropoulos A
    Pharmacol Res; 2016 Sep; 111():556-562. PubMed ID: 27378567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine-induced S-nitrosylation of soluble guanylyl cyclase and expression of phosphodiesterase 1A contribute to dysfunction of longitudinal smooth muscle relaxation.
    Rajagopal S; Nalli AD; Kumar DP; Bhattacharya S; Hu W; Mahavadi S; Grider JR; Murthy KS
    J Pharmacol Exp Ther; 2015 Mar; 352(3):509-18. PubMed ID: 25550199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Halothane attenuates nitric oxide relaxation of rat aortas by competition for the nitric oxide receptor site on soluble guanylyl cyclase.
    Jing M; Ling GS; Bina S; Hart JL; Muldoon SM
    Eur J Pharmacol; 1998 Jan; 342(2-3):217-24. PubMed ID: 9548389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective guanylyl cyclase inhibitor reverses nitric oxide-induced vasorelaxation.
    Olson LJ; Knych ET; Herzig TC; Drewett JG
    Hypertension; 1997 Jan; 29(1 Pt 2):254-61. PubMed ID: 9039111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II augments renal vascular smooth muscle soluble GC expression via an AT
    Galley JC; Hahn SA; Miller MP; Durgin BG; Jackson EK; Stocker SD; Straub AC
    Br J Pharmacol; 2022 Jun; 179(11):2490-2504. PubMed ID: 33963547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells.
    Filippov G; Bloch DB; Bloch KD
    J Clin Invest; 1997 Aug; 100(4):942-8. PubMed ID: 9259594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-β downregulates sGC subunit expression in pulmonary artery smooth muscle cells via MEK and ERK signaling.
    Du L; Roberts JD
    Am J Physiol Lung Cell Mol Physiol; 2019 Jan; 316(1):L20-L34. PubMed ID: 30260287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of nitric oxide-stimulated soluble guanylyl cyclase activity by cytoskeleton-associated proteins in vascular smooth muscle.
    Kollau A; Gesslbauer B; Russwurm M; Koesling D; Gorren ACF; Schrammel A; Mayer B
    Biochem Pharmacol; 2018 Oct; 156():168-176. PubMed ID: 30099008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acrylamide analog as a novel nitric oxide-independent soluble guanylyl cyclase activator.
    Nakane M; Kolasa T; Chang R; Miller LN; Moreland RB; Brioni JD
    J Pharmacol Sci; 2006 Oct; 102(2):231-8. PubMed ID: 17050951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.